Money A2Z Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Were Hedge Funds Right About Souring On Athersys, Inc. (ATHX)?

    www.aol.com/news/were-hedge-funds-souring...

    For premium support please call: 800-290-4726 more ways to reach us

  3. Hedge Funds Are Selling Athersys, Inc. (ATHX) - AOL

    www.aol.com/news/hedge-funds-selling-athersys...

    For premium support please call: 800-290-4726 more ways to reach us

  4. Sotio - Wikipedia

    en.wikipedia.org/wiki/Sotio

    SOTIO Biotech [1] is a Czech biotechnology company focused on clinical-stage research and development of innovative medicines for cancer with operations in Europe, ...

  5. Athersys (ATHX) Down as Ischemic Stroke Study Fails to ... - AOL

    www.aol.com/news/athersys-athx-down-ischemic...

    While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.

  6. Jason Pontin - Wikipedia

    en.wikipedia.org/wiki/Jason_Pontin

    Jason Matthew Daniel Pontin (born 11 May 1967) is a British-born venture capitalist and journalist. He is a General Partner at the venture capital firm of DCVC in Palo Alto, and is a board member and seed investor in a number of life sciences companies.

  7. William Rastetter - Wikipedia

    en.wikipedia.org/wiki/William_Rastetter

    He was a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). [6] [7] [8] Rastetter is also a director of Regulus Therapeutics [9] and Iambic Therapeutics.

  8. Are Institutions Heavily Invested In Athersys, Inc.'s ... - AOL

    www.aol.com/news/institutions-heavily-invested...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Matthew Schissler - Wikipedia

    en.wikipedia.org/wiki/Matthew_Schissler

    Matthew Schissler (born June 9, 1971) is an American business executive who has served in leadership roles in a number of privately and publicly held companies. He's most notable for having founded and managed Cord Blood America, Inc. (CBAI), a company specializing in the harvesting and storage of umbilical stem cells in the U.S. and worldwide.